本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tarsus Pharmaceuticals, Inc.

79.31
-1.8100-2.23%
盤後79.310.00000.00%19:30 EDT
成交量:49.08萬
成交額:3,924.40萬
市值:34.80億
市盈率:-73.27
高:83.23
開:82.27
低:79.18
收:81.12
52周最高:91.53
52周最低:48.20
股本:4,388.30萬
流通股本:3,267.99萬
量比:0.48
換手率:1.50%
股息:- -
股息率:- -
每股收益(TTM):-1.0824
每股收益(LYR):-1.5900
淨資產收益率:-13.68%
總資產收益率:-5.48%
市淨率:10.04
市盈率(LYR):-49.88

資料載入中...

2023/07/25

重要事件披露

Form 8-K - Current report
2023/07/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/28

重要事件披露

Form 8-K - Current report
2023/06/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/15

重要事件披露

Form 8-K - Current report
2023/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/10

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/05

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals